Format

Send to

Choose Destination
Acta Paediatr. 2018 Dec;107(12):2158-2164. doi: 10.1111/apa.14600.

Using clinical and genetic data to predict pulmonary hypertension in bronchopulmonary dysplasia.

Author information

1
Pulmonary Hypertension Group, Center for Perinatal Research, The Research Institute, Nationwide Children's Hospital, Columbus, OH, USA.
2
Department of Pediatrics, The Ohio State University, Columbus, OH, USA.
3
Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
4
Department of Pathology, The Ohio State University, Columbus, OH, USA.
5
Battelle Center for Mathematical Medicine, Columbus, OH, USA.

Abstract

AIM:

Pulmonary hypertension significantly increases morbidity and mortality in infants with bronchopulmonary dysplasia. The frequency of single nucleotide polymorphisms in arginase-1 (ARG1 rs2781666) and dimethylarginine dimethylaminohydrolase-1 (DDAH1 rs480414) genes has been found to differ in a cohort of bronchopulmonary dysplasia patients with pulmonary hypertension (cases) and without pulmonary hypertension (controls). Therefore, we tested the hypothesis that combining these genotypes with phenotypic data would better predict pulmonary hypertension in bronchopulmonary dysplasia patients.

METHODS:

Bronchopulmonary dysplasia patients (n = 79) born at <35 weeks gestation were studied. Pulmonary hypertension was diagnosed by echocardiographic criteria (n = 20). ROC curves to predict pulmonary hypertension in bronchopulmonary dysplasia were generated from genotype and/or clinical data.

RESULTS:

Cases were born at an earlier gestation and weighed less at birth than did controls. ROC curves for rs2781666 had an AUC of 0.61, while rs480414 had an AUC of 0.66. Together, the AUC was 0.70. When clinical data were added to the genetic model, AUC was 0.73.

CONCLUSION:

These findings demonstrate that ROC predictive modelling of pulmonary hypertension in bronchopulmonary dysplasia improves with inclusion of both genotypic and phenotypic data. Further refinement of these types of models could facilitate the implementation of precision medicine approaches to pulmonary hypertension in bronchopulmonary dysplasia.

KEYWORDS:

Arginase; Dimethylarginine dimethylaminohydrolase; Neonatology; Predictive model; Prematurity

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center